Integrated Regional Information Networks - June 6, 2002

Under the scheme, which is novel in Africa, 10,000 infected adults and 5,000 children are to receive treatment thanks to a subsidy of over 80 percent. A cocktail of generic drugs obtained by the government at US $90 per person is being provided to patients at less than US $10. The drugs come from CIPLA Limited, an Indian pharmaceutical company.

The ultimate target is to provide treatment for 10,000 adult people living with HIV/AIDS in 100 hospitals across the country in the first year of the scheme, Shehu Suleiman, permanent secretary in Nigeria's federal ministy of health, said. Another aspect of the treatment programme is aimed at stopping mother-to-child transmissions of HIV. It takes off on 14 June, he added.

But figures collected by the ministry by the middle of May showed that only about 800 patients had registered for the treatment in 25 hospitals designated for that purpose across the country of over 120 million people. "Some of the hospitals had only about 10 patients reporting, only a few had more than 20 people registered," a senior official of the National Institute for Medical Research, which coordinates the programme, told IRIN.

Some HIV/AIDS activists blame the low response on the deep-seated stigma attached to the disease in Nigeria.

"The treatment scheme requires that patients go public with their HIV/AIDS status by coming to the designated hospitals to register," Dupe Onitiri, who is involved in the campaign to reduce HIV/AIDS transmission, told IRIN. "Perhaps the response would have been much better if a confidential treatment programme was being run."

Others feel additional costs may be discouraging people from joining the programme. For instance, participants are required to pay for a series of tests to determine the most suitable doses of the cocktail of drugs for them. Each test costs about US $40, plus a US $10 administrative fee.

"Few people can indeed afford these expenses in a country where the minimum monthly wage is less than $30," Dr Ben Ezeobi, of the Lagos University Teaching Hospital told IRIN. The hospital is one of the treatment centres.

With most of the drugs due to expire by March 2003, there is a danger the scheme may miss many of its targets. However, senior Nigerian health officials said they were aware of the problems and had plans for periodic reviews of the scheme in order to make adjustments and keep it on course to fulfil its objectives.

020606
IR020603

Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980 – 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .